Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sensing the State of the CRM Market

Executive Summary

After years of steady single-digit growth, the cardiac rhythm management market was jump-started this decade by the expansion of implantable cardioverter defibrillators and the development of cardiac resynchronization therapy devices. Those products drove annual growth rates above 20%. But in 2005, this growth came to a screeching halt due to product recalls and other safety issues. To address these concerns, CRM manufacturers are working with the FDA and the Heart Rhythm Society to restore the trust of both implanting physicians and the patient community.

You may also be interested in...



Wireless and Mobile Monitoring: Bringing Health Care Home

The recent proliferation of smart phones and mobile apps has put everything from face-to-face meetings to comparison shopping into the palms of our hands. Wireless technology is changing the way we communicate and do business, and proponents say it could soon have a similar game-changing impact on health care. Indeed, hundreds of mobile health apps are already available for relatively simple tasks such as logging and tracking blood pressure measurements, caloric intake, and sleep habits, but this is only the beginning of what could be a pervasive and increasingly sophisticated technology trend in the years ahead.

HRS 2010: Subcutaneous ICD Generates Excitement, Controversy

In the years since the dawn of the ICD era in the 1980s, perhaps four expansions of the implantable cardioverter defibrillator have captured the imagination of electrophysiologists and signaled unqualified success for the major manufacturers of these life-saving devices. Now, a new generation of ICD--the S-ICD or totally subcutaneous ICD--has the potential to join those sophisticated devices as the next truly evolutionary development in the field. Interest in the S-ICD picked up steam this spring in Denver at the 31st annual scientific sessions of the Heart Rhythm Society, where researchers presented the latest clinical results with the device.

Remote Patient Monitoring: Roadblocks to Full Adoption

Recent advances in patient monitoring technology present a number of opportunities for remote monitoring and self-monitoring of patients outside the clinical setting. While the data captured during real-life situations is of value, not every segment of the health care market is rushing to embrace the latest technology advances in this area, for a variety of reasons. In particular, the market for implantable cardiac rhythm devices sticks out as an area where many physicians (and manufacturers as well) are simply not sure how to utilize all the data that could be harvested via the latest remote monitoring technology.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL043624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel